ICOS and inflammation: In addition to these ICOS-knockout studies, we and others have shown that blocking ICOS inhibits Th2-mediated lung inflammation, and ICOS blockade in vitro resulted in a corresponding decrease in IL-4 and IL-5 production by Th2 cells [15]–[17].